设计和开发一个以人口/文学为基础的西方化饮食指数 (WDI) 以及它对心脏代谢健康的相关性
Miguel Cifuentes1,2, Zahra Hejazi1, Farhad Vahid1
1Nutrition and Health Research Group, Department of Precision Health, Luxembourg Institute of Health, 1445 Strassen, Luxembourg.
Nutrients
|July 30, 2025
概括
一个新的西方化饮食指数 (WDI) 被开发来衡量与非传染性疾病相关的不健康饮食模式的坚持. 高WDI得分表明消费有害的食物,如软饮料和加工品,而较低的得分反映有益的食物,如鱼和坚果.
科学领域:
- 营养科学 营养科学
- 公共卫生 公共卫生
- 饮食评估 饮食评估
背景情况:
- 全球向西方化的饮食模式 (WDPs) 的转变与非传染性疾病 (NCDs) 的增加有关.
- 代谢综合征 (MetS) 经常先于非传染性疾病,如肥胖,2型糖尿病和心血管疾病.
- 需要一个经过验证的工具来评估遵守WDP及其心脏代谢影响.
研究的目的:
- 开发和描述西方化饮食指数 (WDI).
- 评估WDI与心脏代谢健康问题的关联,使用MetS作为代理.
- 量化WDP中特定食品组对健康结果的影响.
主要方法:
- 491篇文章的半系统文献综述为WDI的发展提供了信息.
- 基于研究设计,样本大小和食品健康影响方向,创建了一个评分算法.
- 最终的WDI包含30个食品组/项目.
主要成果:
- 软饮料,加工食品,红肉,和化脂肪显示出最负面的健康影响.
- 食纤维,植物代谢物,维生素,矿物质,坚果/种子和鱼类显示出显著的有益作用.
- 这些食物成分对WDI的系数产生了很大的影响.
结论:
- 在WDI有效地衡量坚持西方化的饮食模式.
- 它与DII和AHEI等现有的饮食质量指数保持一致.
- 世界饮食日可以帮助临床医生和研究人员制定饮食指南和预防饮食相关疾病的预防策略.
相关概念视频
Coronary Artery Disease I: Introduction
58
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58
Obesity
620
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
620
Coronary Artery Disease IV: Preventive Measures
35
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
35
Assessment of the Cardiovascular System I: Subjective Data
467
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
467
Dietary Connections
55.7K
In biological systems, most metabolic pathways are interconnected. The cellular respiration processes that convert glucose to ATP—such as glycolysis, pyruvate oxidation, and the citric acid cycle—tie into those that break down other organic compounds. As a result, various foods—from apples to cheese to guacamole—end up as ATP. In addition to carbohydrates, food also contains proteins and lipids—such as cholesterol and fats. All of these organic compounds are used...
55.7K
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35


